Technology And Equipment Tenders

Expansion Primary School Campus Wildau

Completion of Non -Exclusive Discount Agreement According to Section 130A (8) Sgb V on the Active Ingredient Molizumab - Vv 83

Completion of Non -Exclusive Discount Agreement According to Section 130A (8) Sgb V for the Active Ingredient Fluorouracil (Tolak) - Vv 83

Completion of Non-Exclusive Discount Agreements According to § 130 a (8) Sgb V with the Active Ingredient Infliximab for Intravenous Application

Completion of Non-Exclusive Discount Agreements According to § 130 a (8) Sgb V with the Active Ingredient Infliximab for Subcutaneous Application

Test Tender

Completion not Excl. Pharmaceutical Discount Club. According to Section 130A (8) Sgb V by Means of an Open House Model to the Active Ingredient Interferon Beta-1A for Subcutaneous Injection (Atc Code According to Who: L03ab07)

Completion of Non -Exclusive Discount Agreement According to Section 130A (8) Sgb V for Active Ingredients (Drugs) - Vv 82

Open-House-Original Discount Contracts 2025-09-Cannabis

Completion of Non-Exclusive Discount Agreements According to §130A (8) Sgb V on Various Active Ingredient/En/Combinations with any Time Final Option Within the Framework of the So-Called Open House Procedure